EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome

Ya-Nan Su, Mei-Jiao Wang, Jun-Pu Yang, Xiang-Lu Wu, Min Xia, Mei-Hua Bao, Yu-Bin Ding, Qian Feng, Li-Juan Fu

Frontiers in Endocrinology · 2023

DOI: 10.3389/fendo.2023.1122709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2023. Verfasst von Ya-Nan Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Herbal Medicine, Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, School of trad…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Gastrointestinal Microbiome. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing, Science-Health Joint Medical Scientific Research Project of Chongqing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polycystic ovarian syndrome (PCOS) is a common endocrine disorder characterized by hyperandrogenism, ovarian dysfunction and polycystic ovarian morphology. Gut microbiota dysbiosis and metabolite are associated with PCOS clinical parameters. Yulin Tong Bu formula (YLTB), a traditional Chinese medicine formula, has been recently indicated to be capable of ameliorating polycystic ovary symptoms and correcting abnormal glucose metabolism. However, the therapeutic mechanism of YLTB on PCOS has not been fully elucidated.

Methods

A pseudo sterile mouse model was established during this four-day acclimatization phase by giving the animals an antibiotic cocktail to remove the gut microbiota. Here, the therapeutic effects of YLTB on PCOS were investigated using dehydroepiandrosterone plus high-fat diet-induced PCOS mice model. Female prepuberal mice were randomly divided into three groups; namely, the control group, PCOS group and YLTB (38.68 g·kg -1 ·day -1 ) group. To test whether this effect is associated with the gut microbiota, we performed 16S rRNA sequencing studies to analyze the fecal microbiota of mice. The relationships among metabolites, gut microbiota, and PCOS phenotypes were further explored by using Spearman correlation analysis. Then, the effect of metabolite ferulic acid was then validated in PCOS mice.

Results

Our results showed that YLTB treatment ameliorated PCOS features (ovarian dysfunction, delayed glucose clearance, decreased insulin sensitivity, deregulation of glucolipid metabolism and hormones, etc.) and significantly attenuated PCOS gut microbiota dysbiosis. Spearman correlation analysis showed that metabolites such as ferulic acid and folic acid are negatively correlated with PCOS clinical parameters. The effect of ferulic acid was similar to that of YLTB. In addition, the bacterial species such as Bacteroides dorei and Bacteroides fragilis were found to be positively related to PCOS clinical parameters, using the association study analysis.

Conclusion

These results suggest that YLTB treatment systematically regulates the interaction between the gut microbiota and the associated metabolites to ameliorate PCOS, providing a solid theoretical basis for further validation of YLTB effect on human PCOS trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeGastrointestinal MicrobiomeMiceFemaleHumansAnimalsDysbiosisRNA, Ribosomal, 16SCoumaric Acids

Stichwörter der Autor:innen

YLTB formulaferulic acidgut microbiotametabolitespolycystic ovary syndrome

Substanzen

RNA, Ribosomal, 16Sferulic acidCoumaric Acids

Autor:innen und Institutionen

  • Department of Herbal Medicine, Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, School of traditional Chinese Medicine, Chongqing Medical University, Chongqing, Chi…
  • Joint International Research Laboratory of Reproduction and Development of the Ministry of Education of China, School of Public Health, Chongqing Medical University, Chongqing, China.
  • Department of Physiology, School of Basic Medicine, Chongqing Medical University, Chongqing, China.
  • Department of Gynecology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.
  • Department of Pharmacology, Academician Workstation, Changsha Medical University, Changsha, China.
  • Department of Obstetrics and Gynecology, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Chongqing
  • Science-Health Joint Medical Scientific Research Project of Chongqing
  • Chongqing Municipal Public Health Bureau, Chongqing People's Municipal Government

Zitieren

APA

Su, Y. N., Wang, M. J., Yang, J. P., Wu, X. L., Xia, M., Bao, M. H., Ding, Y. B., Feng, Q., & Fu, L. J. (2023). Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2023.1122709

Vancouver

Su YN, Wang MJ, Yang JP, Wu XL, Xia M, Bao MH, et al. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome. Frontiers in Endocrinology. 2023. doi:10.3389/fendo.2023.1122709

BibTeX
@article{Su2023,
  author = {Su, Ya-Nan and Wang, Mei-Jiao and Yang, Jun-Pu and Wu, Xiang-Lu and Xia, Min and Bao, Mei-Hua and Ding, Yu-Bin and Feng, Qian and Fu, Li-Juan},
  title = {Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome},
  journal = {Frontiers in Endocrinology},
  year = {2023},
  doi = {10.3389/fendo.2023.1122709}
}
Kostenlos starten →